Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

54.5%

6 terminated/withdrawn out of 11 trials

Success Rate

40.0%

-46.5% vs industry average

Late-Stage Pipeline

9%

1 trials in Phase 3/4

Results Transparency

125%

5 of 4 completed trials have results

Key Signals

1 recruiting5 with results

Enrollment Performance

Analytics

N/A
8(88.9%)
Phase 3
1(11.1%)
9Total
N/A(8)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials
NCT05318105Not ApplicableRecruiting

Ultrafiltration Versus IV Diuretics in Worsening Heart Failure

Role: lead

NCT04241718Not ApplicableTerminated

A Feasibility Study on Ultrafiltration and Blood Volume Measurements

Role: lead

NCT04644731Terminated

Ultrafiltration Therapy Registry Using Aquadex (ULTRA-Peds)

Role: lead

NCT01740596Not ApplicableTerminated

C-Pulse® System: A Heart Assist Device Clinical Study

Role: lead

NCT01474200Not ApplicableTerminated

Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment

Role: lead

NCT00815880Not ApplicableCompleted

C-Pulse IDE Feasibility Study- A Heart Assist System

Role: lead

NCT01176370Not ApplicableTerminated

C-Pulse Implantable Counterpulsation Pump (ICP) - A Heart Assist Device

Role: lead

NCT01872949Completed

C-Pulse® System European Multicenter Study

Role: lead

NCT00608491Phase 3Completed

Effectiveness of Ultrafiltration in Treating People With Acute Decompensated Heart Failure and Cardiorenal Syndrome (The CARRESS Study)

Role: collaborator

NCT00319384Not ApplicableWithdrawn

Outpatient Ultrafiltration Therapy in Heart Failure Patients Trial

Role: collaborator

NCT00124137Not ApplicableCompleted

Ultrafiltration Versus Intravenous (IV) Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure: (UNLOAD)

Role: lead

All 11 trials loaded